13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-13, with 69 holding rows worth $241,648,000.
- Accession
- 0001420506-22-000940
- Filer
- CIK 1816307
- Filed
- 2022-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 69 entries on the cover page, a total value of $241,648,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $241,648,000 with VALUE read as thousands by filing date, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSILVERARC CAPITAL, LLC028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 300,000 | $26,964,000 | thousands by filing date | call |
| ATHIRA PHARMA INC | 04746L104 | COM | 10,000 | $26,964,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 308,819 | $18,897,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 443,381 | $14,210,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 425,554 | $11,733,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 2,250,000 | $10,508,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 324,719 | $8,586,000 | thousands by filing date | |
| CERUS CORP | 157085101 | COM | 1,398,400 | $7,677,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 67,442 | $7,096,000 | thousands by filing date | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 1,004,399 | $6,077,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 105,368 | $5,354,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 275,333 | $4,747,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 138,843 | $4,468,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 102,497 | $4,359,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 573,699 | $4,297,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 46,122 | $3,792,000 | thousands by filing date | |
| IMMATICS N.V | N44445109 | SHS | 445,334 | $3,558,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 46,489 | $3,093,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 645,000 | $3,070,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 200,494 | $3,058,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 1,207,385 | $2,898,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 68,709 | $2,759,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 14,836 | $2,662,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 41,002 | $2,543,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 114,004 | $2,502,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 102,067 | $2,399,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 126,136 | $2,332,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 326,872 | $2,327,000 | thousands by filing date | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 185,666 | $2,256,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 7,638 | $1,993,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 20,482 | $1,920,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 1,032,163 | $1,806,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 101,447 | $1,763,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 436,096 | $1,709,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 248,347 | $1,686,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 81,000 | $1,670,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 204,679 | $1,631,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 174,768 | $1,625,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 94,600 | $1,592,000 | thousands by filing date | put |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 500,000 | $1,592,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 10,956 | $1,578,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 101,081 | $1,428,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 25,000 | $1,428,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 300,000 | $1,428,000 | thousands by filing date | call |
| CYCLACEL PHARMACE 6percent PFDCONV | 23254L603 | Stock | 462,659 | $1,411,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 346,405 | $1,292,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 131,151 | $1,283,000 | thousands by filing date | |
| AMRYT PHARMA LTD - SPNR ADR | 03217L106 | COMMON EQUITY | 153,267 | $1,268,000 | thousands by filing date | |
| POLYPID LTD | M8001Q118 | SHS | 218,175 | $1,191,000 | thousands by filing date | |
| LUCIRA HEALTH INC | 54948U105 | COM | 310,734 | $1,109,000 | thousands by filing date | |
| ELOXX PHARMACEUTICALS INC | 29014R103 | COM | 1,950,949 | $1,092,000 | thousands by filing date | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 239,696 | $1,074,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 196,187 | $953,000 | thousands by filing date | |
| COMPUGEN LTD | M25722105 | ORD | 268,596 | $865,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 68,475 | $774,000 | thousands by filing date | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 88,279 | $741,000 | thousands by filing date | |
| APTINYX INC | 03836N103 | COM | 201,600 | $458,000 | thousands by filing date | put |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 30,000 | $386,000 | thousands by filing date | |
| EVOGENE LTD | M4119S104 | SHS | 295,746 | $384,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 235,515 | $264,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 45,538 | $256,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 10,248 | $230,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 102,425 | $197,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,235,784 | $177,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 221,809 | $74,000 | thousands by filing date | |
| Benitec Biopharma, Inc. | 08205P100 | common | 492,880 | $57,000 | thousands by filing date | |
| Renovacor Inc | 75989E114 | Warrant | 104,828 | $33,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 10,659 | $23,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 49,990 | $21,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-22-000940 | this filing | 2022-05-13 | acceptance time not in the bulk data set |